2017
DOI: 10.4067/s0370-41062017000400014
|View full text |Cite
|
Sign up to set email alerts
|

Hipoplasia pontocerebelosa secundaria a deleción en el gen CASK: Caso clínico

Abstract: Introduction: Pontocerebellar hypoplasia (PCH) is a reduction of the size of the cerebellum and pons secondary to an alteration in its development, and can be caused by neurodegenerative diseases of genetic origin, of which there are known 10 subtypes (PCH 1-10), cortical malformations, metabolic and genetic diseases. Objective: To present the case of a child with microcephaly, PCH and West syndrome, in which the genetic study allowed to make the diagnosis of a deletion on chromosome X. Case report: This is a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 14 publications
(40 reference statements)
0
4
0
Order By: Relevance
“…The CASK protein is highly expressed in the central nervous system and engages in brain development and synaptic function. Intriguingly, the function of the CASK gene varies with the periods of brain development (Hsueh, 2006;Rivas et al, 2017). CASK mutations lead to interference of the neuronal migration and consequent neurodevelopmental disorder.…”
Section: Discussionmentioning
confidence: 99%
“…The CASK protein is highly expressed in the central nervous system and engages in brain development and synaptic function. Intriguingly, the function of the CASK gene varies with the periods of brain development (Hsueh, 2006;Rivas et al, 2017). CASK mutations lead to interference of the neuronal migration and consequent neurodevelopmental disorder.…”
Section: Discussionmentioning
confidence: 99%
“…However, some variants are not associated with clinical phenotypes on the database (12/37 in frameshift; 58/227 in missense; and 15/44 in nonsense). To evaluate the association between the mutations of the CASK gene and clinical phenotypes, we investigated 49 reports describing 197 patients with CASK -related disorders [ 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 46 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 ] and classified the cases based on the genders and phenotypes ( Table 2 ).…”
Section: Genetics Of Cask -Related Disordersmentioning
confidence: 99%
“…At the high end of the range is microcephaly with pontine-cerebellar hypoplasia (MICPCH, MIM# 300749; https://omim.org/entry/300749 , last accessed 9 February 2023), a congenital disorder that causes severe psychomotor delay, often with early-onset, hard-to-control epilepsy, optic nerve/retinal abnormalities, and/or short stature. These patients have de novo germline CASK mutations, and most but not all are heterozygous females [ 47 , 49 , 55 57 , 71 , 80 , 100 , 103 , 104 , 112 , 113 , 120 , 128 , 129 , 149 , 153 , 160 ]. In other cases, the phenotypes do not fit neatly into either category, including autism spectrum disorder (ASD) without ID in males or females [ 10 , 64 , 139 ], progressive microcephaly without cerebellar/pontine abnormalities [ 24 ], or focal cortical dysplasia in a female with a large somatic CASK -mutant clone [ 83 ].…”
Section: Introductionmentioning
confidence: 99%